Related Experiment Video
Updated: May 2, 2026
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
8.9K
An in vivo screen implicates PPP2R2D as an inhibitor of T-cell function
Cancer Discovery
|March 6, 2014
Abstract:
The PP2A regulatory subunit PPP2R2D inhibits T-cell proliferation and survival within tumors.
Insights
The regulatory subunit PPP2R2D of protein phosphatase 2A (PP2A) suppresses T-cell proliferation and survival in tumor environments. This finding highlights PPP2R2D as a potential target for enhancing anti-tumor immunity.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- T-cells are crucial for anti-tumor immunity.
- Tumor microenvironments often suppress T-cell function.
- Protein phosphatase 2A (PP2A) is a key regulator of cellular processes.
Discussion:
- The PP2A regulatory subunit PPP2R2D was identified as a novel inhibitor of T-cell proliferation and survival.
- PPP2R2D expression is linked to impaired T-cell function within the tumor microenvironment.
- Understanding PPP2R2D's role is critical for developing immunotherapies.
Key Insights:
- PPP2R2D directly inhibits T-cell proliferation and survival.
- Targeting PPP2R2D may restore T-cell anti-tumor activity.
- This subunit represents a potential therapeutic target in oncology.
Outlook:
- Further research into PPP2R2D's mechanism of action is warranted.
- Developing strategies to inhibit PPP2R2D could enhance cancer immunotherapy efficacy.
- Investigating PPP2R2D in various cancer types will clarify its broader implications.
